Solaris Therapeutics, Inc.

Solaris Therapeutics, Inc., a biological product (except diagnostic) manufacturing company headquartered in the US, has not yet publicly disclosed specific carbon emissions data for recent years. Consequently, detailed information on their Scope 1, Scope 2, or Scope 3 emissions, as well as any absolute reduction figures, is not available.

While specific emissions data is absent, Solaris Therapeutics operates within an industry increasingly focused on environmental responsibility. Companies in the biological product manufacturing sector are increasingly aware of their carbon footprint and the importance of implementing sustainable practices. This includes exploring ways to reduce energy consumption, optimise supply chains, and minimise waste.

As Solaris Therapeutics is not a cascaded entity, there is no inherited emissions data or reduction targets from a parent organisation. The company's climate commitments would therefore be developed independently. Further updates on their environmental performance and climate strategies are anticipated as the company matures and its reporting practices evolve.